Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines Prevention
Research from Catalan Institute of Oncology in cancer vaccines prevention provides new insights
November 4th, 2008
Researchers detail in 'Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia,' new data in cancer vaccines. According to a study from Spain, "Worldwide human papillomavirus (HPV) prevalence in women with normal cytology at any given point in time is approximately 10% indicating that HPV is one of the most common sexually transmitted infections. HPV-16 is consistently the most common type and HPV-18 the second with some minor regional differences." "Furthermore, across the spectrum of cervical lesions, HPV-16 is consistently the most common HPV type contributing to 50-55% of invasive cervical cancer cases...
Source: Cancer Weekly (2008-11-04)
|
